PGP and cancer: Pgp-mediated drug resistance occurs by its rapid internalization, redistribution and increased expression through HIF-1α activity; this facilitates accumulation of the drug in lysosomes, creating a “drug safe house” away from its therapeutic target, and then eventual efflux from the cancer cell (249).